American Healthcare REIT, Inc.
NYSE:AHRREIT - Healthcare Facilities
-$0.35 today
- Market cap
- $13.59B
- Beta
- 0.81
- P/E (TTM)
- 86.9
- EPS (TTM)
- $0.54
- Dividend yield
- 2.15%
Volume 2.30M
Average 2.50M
AHR Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
American Healthcare REIT, Inc.NYSE: AHR
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue grows, but more slowly than its trailing trend
Q3 FY2026 cost of revenue of $577.35M rose 27.0% year over year, behind the +29.1% change in trailing-twelve-month cost of revenue. Sequentially, it fell 15.3% from the prior quarter. Over 3 fiscal years it compounded at +11.9% a year.
Context
- Cost of revenue amounted to 79.4% of revenue in FY2025, down 0.5 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +27.0% toward the trailing-twelve-month pace of +29.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 1.79B USD
- Year-over-year change
- +8.4%
- 4-year CAGR
- +13.5%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.79B | +8.4% |
| FY2024 | 2024-12-31 | 1.65B | +10.1% |
| FY2023 | 2023-12-31 | 1.5B | +17.2% |
| FY2022 | 2022-12-31 | 1.28B | +18.4% |
| FY2021 | 2021-12-31 | 1.08B | — |
Cost of Revenue vs competitors
How AHR compares with its peers on the latest reported figures
- AHR's LTM Sep 2026 cost of revenue of $2.25B is the 3rd highest of the 11 companies compared; the peer median is $222.12M.
- Its year-over-year change of +29.1% is the 7th highest of 10, against a peer median of +131.0%.
- Cost of revenue amounts to 84.3% of revenue for AHR, versus a peer median of 45.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $6.14B | +3.0% | +22.2% | 44.8% | |
| LTM Sep 2026 | $2.58B | +131.0% | +36.4% | 115.1% | |
| LTM Sep 2026 | $2.25B | +29.1% | +11.9% | 84.3% | |
| LTM Jun 2026 | $362.27M | +2568.6% | +250.1% | 28.0% | |
| LTM Jun 2026 | $327.99M | +37.0% | +18.6% | 38.2% | |
| LTM Sep 2026 | $225.99M | +1907.9% | +190.4% | 49.4% | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $218.25M | — | +0.8% | 63.8% |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $213.63M | -4.4% | +0.8% | 62.4% |
| LTM Sep 2026 | $136.24M | +1127.6% | +174.9% | 22.1% | |
| LTM Mar 2026 | $73.93M | +389.6% | +99.4% | 46.9% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $28.46M | -12.9% | -7.3% | 2.8% |
| Peer median (excluding AHR) | $222.12M | +131.0% | +29.3% | 45.9% | |
Competitors are the stored peer set for AHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.26B | 1.62B | 1.86B | 2.07B | 2.26B |
| Cost of Revenue | 1.08B | 1.28B | 1.5B | 1.65B | 1.79B |
| Gross Profit | 182.01M | 335.97M | 356.83M | 416.78M | 466.59M |
| Gross Margin | 14.4% | 20.8% | 19.2% | 20.1% | 20.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 43.2M | 103.1M | 104.99M | 100.8M | 110.17M |
| Operating Expenses | 43.2M | 245.38M | 280.11M | 279.99M | 297.73M |
| Depreciation & Amortization | 157.38M | 200.6M | 237.3M | 221.64M | 225.2M |
| EBITDA | 163M | 233.76M | 324.26M | 315.48M | 359.62M |
| EBITDA Margin | 12.9% | 14.5% | 17.4% | 15.2% | 15.9% |
| Operating Income | 138.81M | 90.59M | 76.72M | 136.79M | 168.87M |
| Operating Margin | 11.0% | 5.6% | 4.1% | 6.6% | 7.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 80.94M | 105.96M | 163.19M | 127.73M | 85.78M |
| Other Income / Expenses | (191.12M) | (163.39M) | (152.94M) | (170.67M) | (120.22M) |
| Income Before Tax | (52.31M) | (72.8M) | (76.22M) | (33.89M) | 48.65M |
| Pre-Tax Margin | -4.1% | -4.5% | -4.1% | -1.6% | 2.2% |
| Income Tax Expense | 956K | 586K | 663K | 1.71M | (22.17M) |
| Net Income | (47.79M) | (81.3M) | (71.47M) | (37.81M) | 69.81M |
| Net Margin | -3.8% | -5.0% | -3.8% | -1.8% | 3.1% |
| EPS (Basic) | (0.72) | (1.23) | (1.08) | (0.29) | 0.42 |
| EPS (Diluted) | (0.72) | (1.23) | (1.08) | (0.29) | 0.42 |
| Weighted Avg Shares | 66.21M | 66.21M | 66.05M | 130.64M | 166.06M |
| Weighted Avg Shares (Diluted) | 66.21M | 66.21M | 66.05M | 130.64M | 166.85M |
American Healthcare REIT, Inc.
NYSE:AHR
Intrinsic Alpha fair value
Locked
Current Price
$58.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.